VYGR – voyager therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

VYGR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/13

11:05 pm

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

Medium Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

Report

12/11

10:59 am

vygr

Institutional investors own a significant stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR) [Yahoo! Finance]

Low Report

Institutional investors own a significant stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR) [Yahoo! Finance]

Report

12/3

12:03 pm

vygr

Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High? [Yahoo! Finance]

Low Report

Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High? [Yahoo! Finance]

Report

12/2

07:08 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $12.00 price target on the stock.

Low Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $12.00 price target on the stock.

Report

11/29

09:06 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.

High Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.

Report

11/20

07:07 am

vygr

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease [Yahoo! Finance]

Medium Report

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease [Yahoo! Finance]

Report

11/20

07:00 am

vygr

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

Medium Report

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

Report

11/18

03:07 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Medium Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Report

11/14

11:23 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $14.00 price target on the stock.

Medium Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $14.00 price target on the stock.

Report

11/14

08:15 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.

Medium Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.

Report

11/14

06:59 am

vygr

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)? [Yahoo! Finance]

High Report

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)? [Yahoo! Finance]

Report

11/13

02:26 am

vygr

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]

Medium Report

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]

Report

11/12

04:01 pm

vygr

Voyager Reports Third Quarter 2024 Financial and Operating Results

Low Report

Voyager Reports Third Quarter 2024 Financial and Operating Results

Report

11/10

02:03 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

Medium Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

Report

11/6

07:00 am

vygr

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

Medium Report

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

Report

11/5

07:00 am

vygr

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Low Report

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Report

11/2

02:10 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Medium Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Report

10/28

11:40 am

vygr

Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]

Low Report

Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]

Report

10/25

11:05 pm

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

Low Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

Report

10/24

03:27 pm

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.

Low Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.

Report

10/17

07:32 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Low Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Report

10/17

07:32 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Low Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Report

10/16

08:24 am

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.

High Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.

Report

10/14

08:23 am

vygr

Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain [Yahoo! Finance]

Low Report

Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain [Yahoo! Finance]

Report

10/11

11:09 pm

vygr

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Low Report

Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.